Verastem, Inc.
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated prot…
Biotechnology
US, Needham [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Verastem, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDVerastem, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Verastem, Inc..
If you want to see a demo, head over to the financial segments of AAPL